36 related articles for article (PubMed ID: 21442773)
1. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
2. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.
Dehn D; Torkko KC; Shroyer KR
Cancer; 2007 Feb; 111(1):1-14. PubMed ID: 17219448
[TBL] [Abstract][Full Text] [Related]
4. A whole-population profile of HPV testing as a test of cure for high-grade cervical dysplasia in NSW, Australia.
Morrell S; Qian L
J Med Screen; 2014 Sep; 21(3):151-62. PubMed ID: 24981084
[TBL] [Abstract][Full Text] [Related]
5. Clearance of human papillomavirus in women treated for cervical dysplasia.
Moore EE; Danielewski JA; Garland SM; Tan J; Quinn MA; Stevens MP; Tabrizi SN
Obstet Gynecol; 2011 Jan; 117(1):101-108. PubMed ID: 21173650
[TBL] [Abstract][Full Text] [Related]
6. Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis.
Ciapponi A; Bardach A; Glujovsky D; Gibbons L; Picconi MA
PLoS One; 2011; 6(10):e25493. PubMed ID: 21991313
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China.
Zhang Q; Dong B; Chen L; Lin T; Tong Y; Lin W; Lin H; Gao Y; Lin F; Sun P
Cancer Manag Res; 2020; 12():2369-2379. PubMed ID: 32308477
[TBL] [Abstract][Full Text] [Related]
8. Epidemiologic modeling of cervical dysplasia with molecular and cytopathological markers.
Scheurer ME; Guillaud M; Tortolero-Luna G; Follen M; Adler-Storthz K
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S163-9. PubMed ID: 17727928
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study.
Foster E; Malloy MJ; Jokubaitis VG; Wrede CDH; Butzkueven H; Sasadeusz J; Van Doornum S; Macrae F; Unglik G; Brotherton JML; van der Walt A
PLoS One; 2020; 15(6):e0234813. PubMed ID: 32555638
[TBL] [Abstract][Full Text] [Related]
10. Chronic and subacute meningitis.
Zunt JR; Baldwin KJ
Continuum (Minneap Minn); 2012 Dec; 18(6 Infectious Disease):1290-318. PubMed ID: 23221842
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis D virus coinfection and superinfection.
Negro F
Cold Spring Harb Perspect Med; 2014 Nov; 4(11):a021550. PubMed ID: 25368018
[TBL] [Abstract][Full Text] [Related]
12. Comparison of HPV Testing and Colposcopy in Detecting Cervical Dysplasia in Patients With Cytological Abnormalities.
Świderska-Kiec J; Czajkowski K; Zaręba-Szczudlik J; Kacperczyk-Bartnik J; Bartnik P; Romejko-Wolniewicz E
In Vivo; 2020; 34(3):1307-1315. PubMed ID: 32354923
[TBL] [Abstract][Full Text] [Related]
13. Influence of Human Papillomavirus Infection on the Natural History of Cervical Intraepithelial Neoplasia 1: A Meta-Analysis.
Liu M; Yan X; Zhang M; Li X; Li S; Jing M
Biomed Res Int; 2017; 2017():8971059. PubMed ID: 28812024
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus genotyping as a predictor of high-grade cervical dysplasia in women with mildly cytologic abnormalities: a two-year follow-up report.
Huang LW; Lin YH; Pan HS; Seow KM; Lin CY
Diagn Cytopathol; 2012 Aug; 40(8):673-7. PubMed ID: 21442773
[TBL] [Abstract][Full Text] [Related]
16. Role of HPV testing in the follow-up of women treated for cervical dysplasia.
Ribaldone R; Boldorini R; Capuano A; Arrigoni S; Di Oto A; Surico N
Arch Gynecol Obstet; 2010 Aug; 282(2):193-7. PubMed ID: 20012636
[TBL] [Abstract][Full Text] [Related]
17. High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?
Twiggs LB; Hopkins M
J Low Genit Tract Dis; 2011 Jul; 15(3):224-30. PubMed ID: 21716051
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
